Revolutionizing Pregnancy Care with Biotics AI

Table of Contents

1. Introduction
2. The Growing Problems in Pregnancy Care
3. The Importance of Early Detection
4. The Role of Biotics AI in Improving Diagnostics
5. How Biotics AI Works
6. Clinical Studies and Results
7. Business Model and Pricing
8. Data Infrastructure and Partnerships
9. Market Landscape and Competition
10. Limitations and Future Developments

The Importance of Early Detection in Pregnancy Care

Pregnancy is a time of great joy and anticipation, but it can also be a time of great anxiety and uncertainty. For many women, the fear of complications and the unknown can be overwhelming. This is especially true for those who are at high risk for complications, such as women with pre-existing medical conditions or those who have had previous pregnancy complications.

The key to ensuring a healthy pregnancy and a healthy baby is early detection and diagnosis of any potential problems. This is where Biotics AI comes in. Biotics AI is a platform that uses artificial intelligence to detect fetal abnormalities and improve the overall quality of diagnostics. In this article, we will explore the growing problems in pregnancy care, the importance of early detection, and the role of Biotics AI in improving diagnostics.

The Growing Problems in Pregnancy Care

Despite advances in medical technology and knowledge, pregnancy care still faces significant challenges. In the United States alone, $16 billion is lost annually as a result of preventable maternal complications. The shortage of OB/GYNs, the growing rate of pregnancy complications, and new legislation negatively impacting maternal diagnostics are making it more difficult to identify problems earlier and prevent tragic outcomes.

Globally, 107 million mothers do not have access to the minimum standard diagnostic ultrasound. This is the number one reason for the misdiagnosis of the vast majority of fetal abnormalities. In the developed world, half of pregnant patients with a fetal malformation are misdiagnosed due to an error by an ultrasound operator. These statistics highlight the urgent need for improved diagnostics and early detection.

The Importance of Early Detection

Early detection is critical in ensuring the best possible outcomes for both mother and baby. The earlier a problem is detected, the more options there are for treatment and management. This can mean the difference between a healthy pregnancy and a high-risk pregnancy, or even life and death.

Biotics AI is designed to improve the quality of diagnostics and ensure that every pregnant patient gets the care they need. By using artificial intelligence to process ultrasounds, Biotics AI can detect pregnancy complications earlier and with improved accuracy and efficiency. This can help to prevent misdiagnosis and ensure that patients receive the appropriate care and treatment.

The Role of Biotics AI in Improving Diagnostics

Biotics AI is a vendor-agnostic, cloud-Based solution that can integrate with any ultrasound machine over a standard API. It validates the presence of all the standard anatomical views and structures that need to be captured, ensuring the appropriate capture of over 80 different anatomical views and regions. This ensures that patients receive an accurate diagnostic screening.

Biotics AI goes beyond quality control and into guided diagnostics. It localizes malformations, bringing them to the Attention of the obstetrician so that the patient can receive quality prenatal care and appropriate treatment. Biotics AI also automates reporting by extracting information and generating documentation, saving hospitals eight minutes per patient on documentation time.

How Biotics AI Works

Biotics AI uses a hybrid pricing model with a subscription-based cost for baseline features and volume-based pricing for API calls. Hospitals are incentivized to purchase the tool through the ROI provided by increased time savings, allowing for increased patient volume, reduction in patient callbacks, and higher hospital reimbursements in the future through NTAP. Biotics AI is building the AI diagnostics platform for reproductive health, with a focus on obstetrics, gynecology, urology, and neonatology.

Biotics AI has built one of the fastest and growing data sets of prenatal ultrasound images, with access to 88 million images to date. It has piloted across eight healthcare institutions and conducted clinical studies on obstetricians that historically performed poor quality ultrasound scans. The completeness rate of their screenings went up by 20%.

Business Model and Pricing

Biotics AI's business model is focused on providing value to physicians in multiple angles. It helps with quality control, making sure that patients receive accurate diagnostics. It provides added efficiencies, saving physicians time on reporting and documentation. Biotics AI is a co-pilot, providing value to physicians in the diagnostic process.

Biotics AI's pricing model is designed to be flexible and scalable. It uses a hybrid pricing model with a subscription-based cost for baseline features and volume-based pricing for API calls. Hospitals are incentivized to purchase the tool through the ROI provided by increased time savings, allowing for increased patient volume, reduction in patient callbacks, and higher hospital reimbursements in the future through NTAP.

Data Infrastructure and Partnerships

Biotics AI has built a data infrastructure that allows it to Collect and analyze large amounts of ultrasound data. It has partnered with university hubs around Egypt and regional institutions in the United States to further expand its training data set and test its data on bias data sets. Biotics AI has built its own AI algorithms internally that do pre-annotation and has built its own R&D team of Med students and obstetricians that then go correct the annotations.

Market Landscape and Competition

Biotics AI is competing with ultrasound manufacturers and other startups that are similarly trying to analyze ultrasound. However, ultrasound manufacturers are not going to spend an immense amount of time on every single indication. They are developing marketplaces and working with companies like Biotics AI to compete with each other. Biotics AI is talking to manufacturers and different providers within the ultrasound space for distribution partnerships.

Limitations and Future Developments

Biotics AI can analyze over 80 different anatomical regions and structures and validate the entire completeness of the screening. It is currently in research and development for malformation localization in each individual plane. Biotics AI is focused on congenital heart conditions and brain conditions and is scaling across the entirety of the anatomy. Biotics AI is continuously growing its data set to build out new algorithms for new indications and to ensure that patients receive the best possible care.